These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28915148)

  • 1. Adult Fmr1 knockout mice present with deficiencies in hippocampal interleukin-6 and tumor necrosis factor-α expression.
    Hodges SL; Nolan SO; Taube JH; Lugo JN
    Neuroreport; 2017 Dec; 28(18):1246-1249. PubMed ID: 28915148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopolysaccharide-induced inflammation leads to acute elevations in pro-inflammatory cytokine expression in a mouse model of Fragile X syndrome.
    Hodges SL; Nolan SO; Tomac LA; Muhammad IDA; Binder MS; Taube JH; Lugo JN
    Physiol Behav; 2020 Mar; 215():112776. PubMed ID: 31838149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional brain volumes changes in adult male FMR1-KO mouse on the FVB strain.
    Lai JK; Lerch JP; Doering LC; Foster JA; Ellegood J
    Neuroscience; 2016 Mar; 318():12-21. PubMed ID: 26794591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice.
    Michalon A; Bruns A; Risterucci C; Honer M; Ballard TM; Ozmen L; Jaeschke G; Wettstein JG; von Kienlin M; Künnecke B; Lindemann L
    Biol Psychiatry; 2014 Feb; 75(3):189-97. PubMed ID: 23910948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of FMRP in AKT/mTOR pathway-mediated hippocampal autophagy in fragile X syndrome.
    Zhang B; Zhang J; Chen H; Qiao D; Guo F; Hu X; Qin C; Jin X; Zhang K; Wang C; Cui H; Li S
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Aug; 134():111036. PubMed ID: 38823765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal hippocampal theta and gamma hypersynchrony produces network and spike timing disturbances in the Fmr1-KO mouse model of Fragile X syndrome.
    Arbab T; Battaglia FP; Pennartz CMA; Bosman CA
    Neurobiol Dis; 2018 Jun; 114():65-73. PubMed ID: 29486296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal neuronal morphology and neurochemistry in the auditory brainstem of Fmr1 knockout rats.
    Ruby K; Falvey K; Kulesza RJ
    Neuroscience; 2015 Sep; 303():285-98. PubMed ID: 26166728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
    Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
    Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal Sleep Architecture and Hippocampal Circuit Dysfunction in a Mouse Model of Fragile X Syndrome.
    Boone CE; Davoudi H; Harrold JB; Foster DJ
    Neuroscience; 2018 Aug; 384():275-289. PubMed ID: 29775702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau reduction attenuates autism-like features in Fmr1 knockout mice.
    Zhao S; Jiang X; Han L; Jiang Y; Wang Y; Meng J; Zhu X; Zhang X; Luo H; Zhang YW
    Mol Autism; 2023 Nov; 14(1):42. PubMed ID: 37936174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model.
    Bilousova TV; Dansie L; Ngo M; Aye J; Charles JR; Ethell DW; Ethell IM
    J Med Genet; 2009 Feb; 46(2):94-102. PubMed ID: 18835858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome.
    Spencer CM; Alekseyenko O; Serysheva E; Yuva-Paylor LA; Paylor R
    Genes Brain Behav; 2005 Oct; 4(7):420-30. PubMed ID: 16176388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic reduction of MMP-9 in the Fmr1 KO mouse partially rescues prepulse inhibition of acoustic startle response.
    Kokash J; Alderson EM; Reinhard SM; Crawford CA; Binder DK; Ethell IM; Razak KA
    Brain Res; 2019 Sep; 1719():24-29. PubMed ID: 31128097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STEP inhibition reverses behavioral, electrophysiologic, and synaptic abnormalities in Fmr1 KO mice.
    Chatterjee M; Kurup PK; Lundbye CJ; Hugger Toft AK; Kwon J; Benedict J; Kamceva M; Banke TG; Lombroso PJ
    Neuropharmacology; 2018 Jan; 128():43-53. PubMed ID: 28943283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein synthesis levels are increased in a subset of individuals with fragile X syndrome.
    Jacquemont S; Pacini L; Jønch AE; Cencelli G; Rozenberg I; He Y; D'Andrea L; Pedini G; Eldeeb M; Willemsen R; Gasparini F; Tassone F; Hagerman R; Gomez-Mancilla B; Bagni C
    Hum Mol Genet; 2018 Jun; 27(12):2039-2051. PubMed ID: 29590342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of BDNF expression in Fmr1 knockout mice worsens cognitive deficits but improves hyperactivity and sensorimotor deficits.
    Uutela M; Lindholm J; Louhivuori V; Wei H; Louhivuori LM; Pertovaara A; Akerman K; Castrén E; Castrén ML
    Genes Brain Behav; 2012 Jul; 11(5):513-23. PubMed ID: 22435671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced phenotypic severity following adeno-associated virus-mediated Fmr1 gene delivery in fragile X mice.
    Gholizadeh S; Arsenault J; Xuan IC; Pacey LK; Hampson DR
    Neuropsychopharmacology; 2014 Dec; 39(13):3100-11. PubMed ID: 24998620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of FMR1 deletion in a subpopulation of post-mitotic neurons in mouse cortex and hippocampus.
    Amiri A; Sanchez-Ortiz E; Cho W; Birnbaum SG; Xu J; McKay RM; Parada LF
    Autism Res; 2014 Feb; 7(1):60-71. PubMed ID: 24408886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of ultrasonic vocalization deficits in a mouse model of Fragile X Syndrome with minocycline treatment or genetic reduction of MMP-9.
    Toledo MA; Wen TH; Binder DK; Ethell IM; Razak KA
    Behav Brain Res; 2019 Oct; 372():112068. PubMed ID: 31271818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndrome.
    Yuskaitis CJ; Beurel E; Jope RS
    Biochim Biophys Acta; 2010 Nov; 1802(11):1006-12. PubMed ID: 20600866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.